Semler Scientific Announces Its Bitcoin Treasury Strategy By Investing.com

Semler Scientific (NASDAQ:), Inc. (Nasdaq: SMLR) announced today that its board of directors has adopted bitcoin as its main treasury reserve asset. Besides, Scientific Semler announced that it has purchased 581 bitcoins for a total amount of $40 millionincluding fees and expenses.

“Our bitcoin treasury and purchasing strategy bitcoin underline our belief that bitcoin is a reliable store of value and a compelling investment,” he said Eric Semler, Scientific Semler president. “bitcoin is now a major asset class with more than $1 billion of the market value. We believe it has unique characteristics as a scarce and finite asset that can serve as a reasonable hedge against inflation and a safe haven amid global instability. We also believe that its digital architectural resilience makes it preferable to gold, which has a market value of approximately 10 times that of bitcoin. Given the difference in value between gold and bitcoinwe believe that bitcoin has the potential to generate huge returns as it gains increasing acceptance as digital gold.

“In addition, we are encouraged by the growing acceptance and global 'institutionalization' of bitcoin — reflected more recently by the Securities and Exchange Commission January 2024 approval of 11 bitcoin exchange-traded funds. These funds have reported more than $13 billion of net inflows, with investments from nearly 1,000 institutions, including global banks, pensions, endowments and registered investment advisors. “It is estimated that more than 10% of all bitcoins are now in the hands of institutions,” he added. Mr. Semler.

Scientific Semler The board of directors and senior management have spent a lot of time examining potential uses of cash, including acquisitions. “After studying several alternatives, we decided that keeping bitcoin would be the best use of our excess cash,” he said Mr. Semler.

In conjunction with his bitcoin treasury strategy, Scientific Semler will continue to focus on its core medical products and services. “We remain dedicated to our customers and our goal of operating a profitable and growing healthcare company,” he said Doug Murphy Chutoriandoctor, Scientific Semler Executive Director. “We are focused on maintaining sales of QuantaFlo® for peripheral arterial disease testing, while pursuing new 510(k) clearance from the FDA with expanded labeling for use as an aid in the diagnosis of other cardiovascular diseases.”

As Scientific Semler continues to generate revenue and free cash flow from QuantaFlo sales, it will proactively evaluate its use of excess cash. bitcoin will serve as Semler Scientific's primary treasury on an ongoing basis, subject to market conditions and Semler Scientific's anticipated cash needs.

More information about Scientific Semler bitcoin The treasury strategy will be published on your website at www.semlerscientific.com.